These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3522415)

  • 1. Suppression of skin allograft rejection by post-transplantation administration of specific anti-lymphocyte serum.
    Sundaresan P; Sainis KB; Phondke GP; Sundaram K
    Immunol Lett; 1986 Apr; 12(4):201-5. PubMed ID: 3522415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of ALS against lymph node lymphocyte subpopulations to prolong the skin allograft survival in mice.
    Rudnicka W; GoĊ›cicka T; Szewczyk K; Zelazowski P; Zablocki B
    Bull Acad Pol Sci Biol; 1976; 24(1):27-31. PubMed ID: 766923
    [No Abstract]   [Full Text] [Related]  

  • 5. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of natural killer cells in the rejection of hamster skin xenografts.
    Gourlay WA; Chambers WH; Monaco AP; Maki T
    Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells.
    Gelfand MC; Paul WE
    J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum.
    Gotoh M; Porter J; Monaco AP; Maki T
    Transplantation; 1988 Feb; 45(2):429-33. PubMed ID: 2449750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of skin grafts in the mouse. The combined used of specific and nonspecific immunosuppression.
    Koene RA; Gerlag PG; McKenzie IF; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Sep; 20(3):241-7. PubMed ID: 1099730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross species immunosuppressive effects of antilymphocyte serum in mice and rats.
    Motoji T; Chiba C
    Transplantation; 1972 Nov; 14(5):536-40. PubMed ID: 4563193
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice.
    Wood ML; Monaco AP
    Transplantation; 1977 Jan; 23(1):78-86. PubMed ID: 65036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
    Jamshidi F; De Fazio SR; Gozzo JJ
    Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
    De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
    Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclosporin A, antilymphocyte serum and donor-specific transfusions on murine delayed-type hypersensitivity and skin graft survival.
    Mottram PL; Mirisklavos A; Dumble LJ; Clunie GJ
    Int Arch Allergy Appl Immunol; 1986; 79(3):296-304. PubMed ID: 3512457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of allograft tolerance with neonatal skin.
    Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
    Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1980 Apr; 29(4):320-3. PubMed ID: 6445103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.